Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that its heart-health ingredient, Sytrinol, has received Generally Recognized As Safe (GRAS) approval by an independent expert panel assembled by AIBMR Life Sciences.
Sytrinol® is a patented and proprietary combination of polymethoxylated flavones and tocotrienols that has been shown in numerous clinical trials to positively affect cardiovascular function.
“The GRAS affirmation for Sytrinol® represents the quality of the compound in its ability to now be incorporated into a range of foods and beverages with value-added health functionality,” says Mosca. “Its trust in the eyes of health-oriented consumers will further propel successful market opportunities and penetration. Sytrinol® has a history of success in the marketplace as a dietary supplement, and now that it has been given GRAS approval, this naturally presents an exciting evolution into the next generation of Sytrinol®-containing foods and beverages.”
Further, according to Sytrinol® developer Najila Guthrie of KGK Synergize, her company has been working with processors to perfect the manufacturing procedures of adding Sytrinol® seamlessly into shakes, beverages, bars, chocolate and other items without incurring solubility problems and to neutralize the naturally occurring taste of orange peel.
Proprietary Nutritionals, Inc., a subsidiary of Pharmachem Laboratories, Inc., is located in Kearny, New Jersey, USA. PNI markets Celadrin® Joint Flexibility & Relief, and other patented, scientifically proven, branded ingredients to the nutraceuticals industry. For further information, visit www.celadrininfo.com or call 519/647-2071.